Skip to main navigation Skip to search Skip to main content

SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4

  • Konstantinos Tzelepis
  • , Etienne De Braekeleer
  • , Demetrios Aspris
  • , Isaia Barbieri
  • , M. S. Vijayabaskar
  • , Wen Hsin Liu
  • , Malgorzata Gozdecka
  • , Emmanouil Metzakopian
  • , Hamish D. Toop
  • , Monika Dudek
  • , Samuel C. Robson
  • , Francisco Hermida-Prado
  • , Yu Hsuen Yang
  • , Roya Babaei-Jadidi
  • , Dimitrios A. Garyfallos
  • , Hannes Ponstingl
  • , Joao M.L. Dias
  • , Paolo Gallipoli
  • , Michael Seiler
  • , Silvia Buonamici
    • Binje Vick, Andrew J. Bannister, Roland Rad, Rab K. Prinjha, John C. Marioni, Brian Huntly, Jennifer Batson, Jonathan C. Morris, Cristina Pina, Allan Bradley, Irmela Jeremias, David O. Bates, Kosuke Yusa, Tony Kouzarides, George S. Vassiliou
  • Wellcome Sanger Institute
  • University of Cambridge
  • Karaiskakio Foundation
  • Helmholtz Zentrum München German Research Center for Environmental Health
  • University of New South Wales
  • Exonate Ltd
  • University of Portsmouth
  • Cambridge University Hospitals NHS Foundation Trust
  • Eisai Inc.
  • German Cancer Research Center
  • Cellzome GmbH
  • European Bioinformatics Institute
  • Ludwig-Maximilians-Universität München
  • The University of Nottingham Medical School

Research output: Contribution to journal › Article › peer-review

72 Scopus citations

Fingerprint

Dive into the research topics of 'SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4'. Together they form a unique fingerprint.
Sort by

Keyphrases

Biochemistry, Genetics and Molecular Biology